Stress Phenotypes and Preterm Birth: Immune and Energetic Cellular Dysregulation and the Preventive Effect of Social Support
压力表型和早产:免疫和能量细胞失调以及社会支持的预防作用
基本信息
- 批准号:10410500
- 负责人:
- 金额:$ 67.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-18 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AcuteAffectAsthmaAttention deficit hyperactivity disorderBiologicalBiological MarkersBirthBirth RateBlack raceBloodCardiovascular DiseasesCellsChronic Kidney FailureDataDiscriminationDisease OutcomeFirst Pregnancy TrimesterFunctional disorderFutureGene ExpressionGene Expression ProfileGenomeGestational AgeHairHealthHispanicHospitalsHourHydrocortisoneHypertensionImmuneInfantInflammatoryInheritedInterventionKidney DiseasesKnowledgeLaboratoriesLifeLife StressMaternal HealthMediatingMental DepressionMinority WomenMitochondriaMitochondrial DNAMolecularMoodsMothersNeonatal MortalityNot Hispanic or LatinoOutcomePhenotypePhysiologicalPlacentaPlasmaPregnancyPregnant WomenPremature BirthPreventionPreventivePsyche structurePsychological StressPsychosocial FactorPsychosocial StressRiskSamplingSecond Pregnancy TrimesterSocial supportSocioeconomic StatusStressTestingTissuesUmbilical Cord BloodUnited StatesWheezingWomanblack womencytokineethnic differenceexperiencefetalimmune functionimmunological statusindexingintergenerationalmaternal stressmonocyteneonatal morbiditynovelpediatric traumaperceived discriminationperceived stresspotential biomarkerpsychobiologypsychosocialracial and ethnicracial and ethnic disparitiesstress reactivitytooltransmission process
项目摘要
PROJECT ABSTRACT
At odds with common assumptions — and hope, pregnancy ends in preterm birth (PTB) for approximately 1 in
10 women. Yearly PTB affects 15 million infants worldwide and 386,580 in the United States. PTB is the leading
cause of global, and U.S., neonatal mortality and morbidity and is associated with future risk for poor physical
(higher blood pressure, chronic kidney disease, wheeze/asthma) and mental (ADHD, IQ decrements) health.
Maternal health is not spared: women who deliver preterm are at an increased risk for depression, hypertension,
cardiovascular and renal disease later in life. In the U.S., the racial and ethnic disparities in PTB rates are
dramatic and independent of socio-economic status (SES): overall, 14.12% for Non-Hispanic Black compared
to 9.09% for Non-Hispanic White women. Psychosocial stress and childhood trauma each are associated with
risk for PTB. PTB has an intergenerational impact: mothers born preterm are more likely to give birth pretern,
especially amongst Black women. Biomarkers to predict PTB have proven unsuccessful, and do not account for
this emerging recognition of intergenerational transmission of PTB risk specifically via maternal heritage.
Mitochondria, which contain their own genome, the mitochondria DNA, are inherited from the mother and
represent a potential intersection point between psychosocial experiences and their biological embedding,
including via immune dysregulation, in underlying disease outcomes. We aim to apply a mitochondria
psychobiology approach to delineate by which mechanisms life stress — including discrimination and childhood
trauma — results in disproportionate risk of PTB in minority women, and evaluate mitochondria as potential
biomarkers of this birth outcome. In a sample of post-attrition n=175 pregnant women we will test the following
three aims: Aim 1: To determine whether a data driven approach to multiple, 1st trimester psychosocial (self-
report stress discrimination, 24-hour ambulatory mood, social support), lifecourse (hair cortisol, childhood
trauma), and biological variables (acute laboratory physiological stress reactivity) generate unique stress profiles
that partially explain the racial/ethnic differences in gestational age at birth. Aim 2: To identify molecular indices
of mitochondrial and immune functioning in the mother (3x blood draw), placenta, and fetal cord blood that
mediate the association between 1st trimester maternal stress phenotypes and risk for earlier gestational age at
birth. Aim 3: To evaluate if reduction in stress levels and/or improvement in social support over the course of
pregnancy is associated with molecular indices of mitochondrial and immune functioning and (exploratory)
reduced risk of earlier birth relative to national and hospital norms. This new conceptual framing of this adverse
health outcome (1) incorporates evidence of the psychosocial factors contributing to risk, (2) aims to account for
the racial/ethnic disparities, and (3) harnesses cutting-edge mitochondria knowledge and tools to better
characterize PTB’s pathophysiology and identify novel targets for its intervention and prevention.
项目摘要
与常见的假设和希望不同的是,怀孕以早产 (PTB) 告终的概率约为 1%
10 名女性。每年 PTB 影响全球 1500 万婴儿,美国 386,580 名婴儿。 PTB 是领先的
导致全球和美国新生儿死亡率和发病率的原因,并与未来身体状况不佳的风险相关
(高血压、慢性肾病、喘息/哮喘)和精神(多动症、智商下降)健康。
孕产妇健康也未能幸免:早产的女性患抑郁症、高血压、
晚年发生心血管和肾脏疾病。在美国,PTB 率的种族和民族差异是
戏剧性且独立于社会经济地位 (SES):总体而言,非西班牙裔黑人为 14.12%
非西班牙裔白人女性的比例为 9.09%。心理社会压力和童年创伤都与
PTB 风险。 PTB 具有代际影响:早产母亲更有可能早产,
尤其是在黑人女性中。预测 PTB 的生物标志物已被证明是不成功的,并且不能解释
人们逐渐认识到肺结核风险的代际传播,特别是通过母系遗传。
线粒体含有自己的基因组,即线粒体 DNA,是从母亲遗传而来的
代表心理社会体验与其生物嵌入之间的潜在交叉点,
包括通过免疫失调导致潜在疾病的结果。我们的目标是应用线粒体
心理生物学方法来描述生活压力的机制——包括歧视和童年
创伤——导致少数族裔女性患 PTB 的风险不成比例,并评估线粒体的潜在风险
该出生结果的生物标志物。在 n=175 名孕妇的自然减员样本中,我们将测试以下内容
三个目标: 目标 1:确定数据驱动的方法是否可以解决多个妊娠第一个月的心理社会问题(自我
报告压力歧视、24小时动态情绪、社会支持)、生命历程(头发皮质醇、童年
创伤)和生物变量(急性实验室生理应激反应)产生独特的应激分布
这部分解释了出生时胎龄的种族/民族差异。目标 2:确定分子指数
母亲(抽血 3 次)、胎盘和胎儿脐带血中的线粒体和免疫功能
介导妊娠第一期母亲应激表型与早孕年龄风险之间的关联
出生。目标 3:评估在治疗过程中压力水平是否降低和/或社会支持是否得到改善
怀孕与线粒体和免疫功能的分子指数相关,并且(探索性)
相对于国家和医院标准,早产风险降低。这种不利的新概念框架
健康结果 (1) 纳入了导致风险的心理社会因素的证据,(2) 旨在解释
种族/民族差异,以及(3)利用尖端的线粒体知识和工具更好地
描述 PTB 的病理生理学特征并确定其干预和预防的新目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CYNTHIA GYAMFI-BANNERMAN其他文献
CYNTHIA GYAMFI-BANNERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CYNTHIA GYAMFI-BANNERMAN', 18)}}的其他基金
PREBIC Global 2020 Annual Meeting in Ghana
加纳 PREBIC 2020 年全球年会
- 批准号:
10481157 - 财政年份:2021
- 资助金额:
$ 67.26万 - 项目类别:
Stress Phenotypes and Preterm Birth: Immune and Energetic Cellular Dysregulation and the Preventive Effect of Social Support
压力表型和早产:免疫和能量细胞失调以及社会支持的预防作用
- 批准号:
10618991 - 财政年份:2021
- 资助金额:
$ 67.26万 - 项目类别:
Randomized Trial of Antenatal Late Preterm Steroids (ALPS) - Clinical Coordinatin
产前晚期早产类固醇 (ALPS) 的随机试验 - 临床协调
- 批准号:
8120579 - 财政年份:2010
- 资助金额:
$ 67.26万 - 项目类别:
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)
产前皮质类固醇随机试验后出生队列的肺部并发症:ALPS 随访研究 - 临床协调中心 (ALPS-FS: CCC)
- 批准号:
9977250 - 财政年份:2010
- 资助金额:
$ 67.26万 - 项目类别:
Randomized Trial of Antenatal Late Preterm Steroids (ALPS) - Clinical Coordinatin
产前晚期早产类固醇 (ALPS) 的随机试验 - 临床协调
- 批准号:
7770407 - 财政年份:2010
- 资助金额:
$ 67.26万 - 项目类别:
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)
产前皮质类固醇随机试验后出生队列的肺部并发症:ALPS 随访研究 - 临床协调中心 (ALPS-FS: CCC)
- 批准号:
9176913 - 财政年份:2010
- 资助金额:
$ 67.26万 - 项目类别:
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)
产前皮质类固醇随机试验后出生队列的肺部并发症:ALPS 随访研究 - 临床协调中心 (ALPS-FS: CCC)
- 批准号:
9345579 - 财政年份:2010
- 资助金额:
$ 67.26万 - 项目类别:
Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)
产前皮质类固醇随机试验后出生队列的肺部并发症:ALPS 随访研究 - 临床协调中心 (ALPS-FS: CCC)
- 批准号:
10511115 - 财政年份:2010
- 资助金额:
$ 67.26万 - 项目类别:
Randomized Trial of Antenatal Late Preterm Steroids (ALPS) - Clinical Coordinatin
产前晚期早产类固醇 (ALPS) 的随机试验 - 临床协调
- 批准号:
8306803 - 财政年份:2010
- 资助金额:
$ 67.26万 - 项目类别:
Maternal-Fetal Medicine Units (MFMU) Network
母胎医学单位 (MFMU) 网络
- 批准号:
9229560 - 财政年份:2001
- 资助金额:
$ 67.26万 - 项目类别:
相似海外基金
Positive Affect and Pediatric Asthma: An Innovative Positive Psychology Model to Improve Asthma Management and Health
积极情绪与小儿哮喘:改善哮喘管理和健康的创新积极心理学模型
- 批准号:
10712703 - 财政年份:2023
- 资助金额:
$ 67.26万 - 项目类别:
How the immune response can affect influenza virus and asthma
免疫反应如何影响流感病毒和哮喘
- 批准号:
nhmrc : GNT1054081 - 财政年份:2013
- 资助金额:
$ 67.26万 - 项目类别:
Early Career Fellowships
How do thick airway walls affect airway hyperresponsiveness in asthma?
气道壁厚如何影响哮喘气道高反应性?
- 批准号:
nhmrc : 512387 - 财政年份:2008
- 资助金额:
$ 67.26万 - 项目类别:
NHMRC Project Grants
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
- 批准号:
6566335 - 财政年份:2000
- 资助金额:
$ 67.26万 - 项目类别:
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
- 批准号:
6504483 - 财政年份:2000
- 资助金额:
$ 67.26万 - 项目类别:
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
- 批准号:
6304309 - 财政年份:1999
- 资助金额:
$ 67.26万 - 项目类别:
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
- 批准号:
6114202 - 财政年份:1998
- 资助金额:
$ 67.26万 - 项目类别:
The way in which newly discovered protein messengers in the lung affect asthma
肺部新发现的蛋白质信使影响哮喘的方式
- 批准号:
nhmrc : 970947 - 财政年份:1997
- 资助金额:
$ 67.26万 - 项目类别:
NHMRC Project Grants
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
- 批准号:
6275437 - 财政年份:1997
- 资助金额:
$ 67.26万 - 项目类别:
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME
哪些家庭过程会影响儿童哮喘的结局
- 批准号:
6245226 - 财政年份:1997
- 资助金额:
$ 67.26万 - 项目类别:














{{item.name}}会员




